Ignite Creation Date:
2025-12-25 @ 3:52 AM
Ignite Modification Date:
2026-02-06 @ 5:54 PM
Study NCT ID:
NCT03943602
Status:
UNKNOWN
Last Update Posted:
2021-02-25
First Post:
2019-03-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)
Sponsor:
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CaboPen
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None